Have a feature idea you'd love to see implemented?
Let us know!
CLYM Climb Bio Inc.
Price (delayed)
$3
Market cap
$201.67M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.13
Enterprise value
$55.55M
Highlights
Climb Bio's equity has soared by 99% YoY
CLYM's debt has dropped by 87% year-on-year and by 42% since the previous quarter
CLYM's quick ratio has soared by 53% YoY but it is down by 5% from the previous quarter
CLYM's net income has dropped by 76% year-on-year and by 8% since the previous quarter
Climb Bio's EPS has decreased by 45% YoY
Key stats
What are the main financial stats of CLYM
Market
Valuations
Earnings
Shares outstanding
67.22M
Market cap
$201.67M
Enterprise value
$55.55M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.92
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$69.12M
EBITDA
-$68.85M
Free cash flow
-$10.99M
Per share
Balance sheet
Liquidity
EPS
-$2.13
Free cash flow per share
-$0.16
Book value per share
$3.26
Revenue per share
$0
TBVPS
$3.32
Total assets
$222.2M
Total liabilities
$3.42M
Debt
$58,000
Equity
$218.78M
Working capital
$194.19M
Debt to equity
0
Current ratio
57.73
Quick ratio
56.49
Net debt/EBITDA
2.12
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-41.4%
Return on equity
-42.2%
Return on invested capital
-312.9%
Return on capital employed
-31.6%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CLYM stock price
How has the Climb Bio stock price performed over time
Intraday
-2.6%
1 week
-6.1%
1 month
-37.5%
1 year
19.05%
YTD
11.11%
QTD
-41.06%
Financial performance
How have Climb Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$76.23M
Net income
-$69.12M
Gross margin
N/A
Net margin
N/A
CLYM's net income has dropped by 76% year-on-year and by 8% since the previous quarter
The operating income has plunged by 71% YoY and by 10% from the previous quarter
Growth
What is Climb Bio's growth rate over time
Valuation
What is Climb Bio stock price valuation
P/E
N/A
P/B
0.92
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Climb Bio's EPS has decreased by 45% YoY
Climb Bio's equity has soared by 99% YoY
The price to book (P/B) is 8% less than the last 4 quarters average of 1.0
Efficiency
How efficient is Climb Bio business performance
The return on assets has declined by 28% year-on-year but it rose by 10% since the previous quarter
The company's return on equity fell by 26% YoY but it rose by 10% QoQ
CLYM's ROIC is up by 16% QoQ
Dividends
What is CLYM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CLYM.
Financial health
How did Climb Bio financials performed over time
The total assets has surged by 97% year-on-year
CLYM's quick ratio has soared by 53% YoY but it is down by 5% from the previous quarter
CLYM's debt is 100% smaller than its equity
Climb Bio's equity has soared by 99% YoY
CLYM's debt has dropped by 87% year-on-year and by 42% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.